Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2005-03-01 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHANTONNAY (85110), Vendee
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU CENTRE : revenue, balance sheet and financial ratios
PHARMACIE DU CENTRE is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHANTONNAY (85110),
this company of category PME
shows in 2025 a net income positive of 133 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CENTRE (SIREN 481017051)
Indicator
2025
2024
2023
2022
2021
2020
2019
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
132 828 €
128 251 €
46 627 €
155 978 €
153 758 €
112 942 €
126 513 €
5 704 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DU CENTRE generates positive net income of 133 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 6 k€ -> 133 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
132 828 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 115%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
115.476%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
40.878%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2019
2020
2021
2022
2023
2024
2025
Debt ratio
0.0
244.011
157.891
86.812
90.878
124.282
93.098
115.476
Financial autonomy
30.338
26.112
33.863
45.864
47.12
30.997
46.05
40.878
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
115.482025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+7 pts over 3 years
In 2025, the debt ratio of PHARMACIE DU CENTRE (115.48) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
40.88%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+6 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU CENTRE (40.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 228.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
228.724
Liquidity indicators evolution PHARMACIE DU CENTRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
281.77
289.128
272.605
181.312
303.224
123.609
83.132
228.724
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
228.722025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+42 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU CENTRE (228.72) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DU CENTRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU CENTRE is estimated at
2 109 988 €
(range 1 431 848€ - 3 310 862€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1431k€2109k€3310k€
2 109 988 €Range: 1 431 848€ - 3 310 862€
NAF 5 année 2025
Valuation method used
Net Income Multiple
132 828 €
×
15.9x
=2 109 989 €
Range: 1 431 848€ - 3 310 863€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CENTRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CENTRE
What is the revenue of PHARMACIE DU CENTRE ?
The revenue of PHARMACIE DU CENTRE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU CENTRE profitable?
Yes, PHARMACIE DU CENTRE generated a net profit of 133 k€ in 2025.
Where is the headquarters of PHARMACIE DU CENTRE ?
The headquarters of PHARMACIE DU CENTRE is located in CHANTONNAY (85110), in the department Vendee.
Where to find the tax return of PHARMACIE DU CENTRE ?
The tax return of PHARMACIE DU CENTRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CENTRE operate?
PHARMACIE DU CENTRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart